Dendronized Polymer‐Derived Nanomedicines for Mitochondrial Dynamics Regulation and Immune Modulation
Advanced Materials · 2024-06 · 36 (25)
DOI: 10.1002/adma.202400582 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 25.03.2024. Verfasst von Xingyu Hou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Huaxi MR Research Center (HMRRC), Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Bi…. Hauptthemen laut MEDLINE: Nanomedicine, Polymers, Deoxycytidine, Gemcitabine. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Science and Technology Major Project of China, 1·3·5 project for disciplines of excellence, West China Hospital, Sichuan University.
Abstract (Originalsprache)
The effects of dendron side chains in polymeric conjugates on tumor penetration and antigen presentation are systematically examined. Three polymer‐gemcitabine (Gem) conjugates (pG0‐Gem, pG1‐Gem, pG2‐Gem) are designed and prepared. The pG2‐Gem conjugate uniquely binds to the mitochondria of tumor cells, thus regulating mitochondrial dynamics. The interaction between the pG2‐Gem conjugate and the mitochondria promotes great penetration and accumulation of the conjugate at the tumor site, resulting in pronounced antitumor effects in an animal model. Such encouraging therapeutic effects can be ascribed to immune modulation since MHC‐1 antigen presentation is significantly enhanced due to mitochondrial fusion and mitochondrial metabolism alteration after pG2‐Gem treatment. Crucially, the drug‐free dendronized polymer, pG2, is identified to regulate mitochondrial dynamics, and the regulation is independent of the conjugated Gem. Furthermore, the combination of pG2‐Gem with anti‐PD‐1 antibody results in a remarkable tumor clearance rate of 87.5% and a prolonged survival rate of over 150 days, demonstrating the potential of dendronized polymers as an innovative nanoplatform for metabolic modulation and synergistic tumor immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Huaxi MR Research Center (HMRRC), Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, Ch…
- Functional and Molecular Imaging Key Laboratory of Sichuan Province, and Research Unit of Psychoradiology, Chinese Academy of Medical Sciences, Chengdu, 610041, China.
- Department of Radiology, West China Xiamen Hospital of Sichuan University, Xiamen, 361000, China.
Förderung
- National Natural Science Foundation of China
- National Science and Technology Major Project of China
- 1·3·5 project for disciplines of excellence, West China Hospital, Sichuan University
Zitieren
APA
Hou, X., Pan, D., Zhong, D., Gong, Q., & Luo, K. (2024). Dendronized Polymer‐Derived Nanomedicines for Mitochondrial Dynamics Regulation and Immune Modulation. Advanced Materials, 36(25). https://doi.org/10.1002/adma.202400582
Vancouver
Hou X, Pan D, Zhong D, Gong Q, Luo K. Dendronized Polymer‐Derived Nanomedicines for Mitochondrial Dynamics Regulation and Immune Modulation. Advanced Materials. 2024;36(25). doi:10.1002/adma.202400582
BibTeX
@article{Hou2024,
author = {Hou, Xingyu and Pan, Dayi and Zhong, Dan and Gong, Qiyong and Luo, Kui},
title = {Dendronized Polymer‐Derived Nanomedicines for Mitochondrial Dynamics Regulation and Immune Modulation},
journal = {Advanced Materials},
year = {2024},
volume = {36},
number = {25},
doi = {10.1002/adma.202400582}
}
EUVIMED